世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000036072

遺伝子編集市場調査レポート 2030 年までの予測

Market Research Future

Gene editing Market Research Report Forecast to 2030

発刊日 2023/08

言語英語

体裁PDF/120ページ

ライセンス/価格120ページ

0000036072

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

市場概要
遺伝子編集の市場規模は、予測期間中に20.9%のCAGRを記録すると予測されます。key drivesの数の増加と遺伝子探索に対する助成金の拡大が、市場の発展を推進する主な要因です。ゲノム編集とは、あらゆる生命体の遺伝データを変更するために使用される手順と方法を指します。 ゲノム編集には、遺伝子組み換え技術を利用した多くの分野での遺伝子の変更が含まれており、これにより付加精度が向上し、細胞の毒性が軽減されます。 さまざまな革新技術により、研究者は生物の DNA を改変することができます。これらの進歩によって、ゲノム内の明示的な領域で遺伝物質を追加、消去、または変更できるようになります。

レポート詳細

目次

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY
1.1 OVERVIEW

2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION

4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING FUNDING FOR GENETIC RESEARCH
4.2.2 RISING INCIDENCE OF GENETIC DISORDERS
4.2.3 GROWING NUMBER OF STRATEGIC INITIATIVES
4.3 RESTRAINTS
4.3.1 OFF-TARGET EFFECTS OF CRISPR TECHNOLOGY
4.3.2 HIGH COST OF EQUIPMENT
4.4 OPPORTUNITIES
4.4.1 INCREASING APPLICATION AREAS OF GENE EDITING

5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D DESIGNING
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION & SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE GLOBAL GENE EDITING MARKET
5.3.1 IMPACT ON SUPPLY CHAIN
5.3.2 IMPACT ON REGIONS
5.3.3 IMPACT ON SUPPLY GAP ANALYSIS
5.3.4 IMPACT ON PRICING

6 GLOBAL GENE EDITING MARKET, BY TECHNOLOGY
6.1 OVERVIEW
6.2 CRISPR
6.3 TALEN
6.4 ZFN
6.5 ANTISENSE
6.6 OTHERS

7 GLOBAL GENE EDITING MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 GENETIC ENGINEERING
7.3 GENE THERAPY
7.4 CELL LINE ENGINEERING
7.5 OTHERS

8 GLOBAL GENE EDITING MARKET, BY END USER
8.1 OVERVIEW
8.2 BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
8.3 CONTRACT RESEARCH ORGANIZATIONS
8.4 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES

9 GLOBAL GENE EDITING MARKET, BY REGION
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 FRANCE
9.3.3 UK
9.3.4 ITALY
9.3.5 SPAIN
9.3.6 REST OF EUROPE
9.4 ASIA-PACIFIC
9.4.1 CHINA
9.4.2 INDIA
9.4.3 JAPAN
9.4.4 AUSTRALIA
9.4.5 SOUTH KOREA
9.4.6 REST OF ASIA-PACIFIC
9.5 REST OF THE WORLD
9.5.1 MIDDLE EAST
9.5.2 AFRICA
9.5.3 LATIN AMERICA

10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPETITIVE BENCHMARKING
10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL GENE EDITING MARKET
10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL GENE EDITING MARKET
10.5 KEY DEVELOPMENT ANALYSIS
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
10.6.1 PRODUCT EXPANSION AND LAUNCH
10.6.2 AGREEMENT/COLLABORATION
10.7 FINANCIAL MATRIX
10.7.1 SALES (USD MILLION), 2021
10.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2021

11 COMPANY PROFILES
11.1 BIO-RAD LABORATORIES, INC
11.1.1 COMPANY OVERVIEW
11.1.2 FINANCIAL OVERVIEW
11.1.3 PRODUCTS OFFERED
11.1.4 KEY DEVELOPMENTS
11.1.5 SWOT ANALYSIS
11.1.6 KEY STRATEGIES
11.2 GE HEALTHCARE
11.2.1 COMPANY OVERVIEW
11.2.2 FINANCIAL OVERVIEW
11.2.3 PRODUCTS OFFERED
11.2.4 KEY DEVELOPMENTS
11.2.5 SWOT ANALYSIS
11.2.6 KEY STRATEGIES
11.3 GENSCRIPT
11.3.1 COMPANY OVERVIEWS
11.3.2 FINANCIAL OVERVIEW
11.3.3 PRODUCTS OFFERED
11.3.4 KEY DEVELOPMENTS
11.3.5 SWOT ANALYSIS
11.3.6 KEY STRATEGIES
11.4 INTEGRATED DNA TECHNOLOGIES, INC
11.4.1 COMPANY OVERVIEW
11.4.2 FINANCIAL OVERVIEW
11.4.3 PRODUCTS OFFERED
11.4.4 KEY DEVELOPMENTS
11.4.5 KEY STRATEGIES
11.5 NEW ENGLAND BIOLABS
11.5.1 COMPANY OVERVIEW
11.5.2 FINANCIAL OVERVIEW
11.5.3 PRODUCTS OFFERED
11.5.4 KEY DEVELOPMENTS
11.5.5 KEY STRATEGIES
11.6 SANGAMO THERAPEUTICS
11.6.1 COMPANY OVERVIEW
11.6.2 FINANCIAL OVERVIEW
11.6.3 PRODUCTS OFFERED
11.6.4 KEY DEVELOPMENTS
11.6.5 SWOT ANALYSIS
11.6.6 KEY STRATEGIES
11.7 THERMO FISHER SCIENTIFIC, INC
11.7.1 COMPANY OVERVIEW
11.7.2 FINANCIAL OVERVIEW
11.7.3 PRODUCTS OFFERED
11.7.4 KEY DEVELOPMENTS
11.7.5 SWOT ANALYSIS
11.7.6 KEY STRATEGIES
11.8 LONZA
11.8.1 COMPANY OVERVIEW
11.8.2 FINANCIAL OVERVIEW
11.8.3 PRODUCTS OFFERED
11.8.4 KEY DEVELOPMENTS
11.8.5 KEY STRATEGIES
11.9 HORIZON DISCOVERY LTD
11.9.1 COMPANY OVERVIEW
11.9.2 FINANCIAL OVERVIEW
11.9.3 PRODUCTS OFFERED
11.9.4 KEY DEVELOPMENTS
11.9.5 KEY STRATEGIES
11.10 ORIGENE TECHNOLOGIES, INC
11.10.1 COMPANY OVERVIEW
11.10.2 FINANCIAL OVERVIEW
11.10.3 PRODUCTS OFFERED
11.10.4 KEY DEVELOPMENTS
11.10.5 KEY STRATEGIES

12 APPENDIX
12.1 REFERENCES
12.2 RELATED REPORTS

この商品のレポートナンバー

0000036072

TOP